Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Massaro

Showing results (351-360 of 422) with videos related to

Pageof 43
Sort By:
Neurocritical Care|August 17, 2014
Thromboelastography defines late hypercoagulability after TBI: a pilot studyAllie M Massaro, Sean Doerfler, Kelsey Nawalinski, et al.
Journal of Vascular and Interventional Radiology : JVIR|August 3, 2013
Correlation of patient-reported symptom outcomes and treadmill test outcomes after treatment for aortoiliac claudicationTimothy P Murphy, Matthew R Reynolds, David J Cohen, et al.
Neurology|March 29, 2007
Inflammatory biomarkers are associated with total brain volume: the Framingham Heart StudyA L Jefferson, J M Massaro, P A Wolf, et al.
American Heart Journal|January 15, 2019
Blood kidney injury molecule-1 predicts short and longer term kidney outcomes in patients undergoing diagnostic coronary and/or peripheral angiography-Results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) studyNasrien E Ibrahim, Cian P McCarthy, Shreya Shrestha, et al.
The American Journal of Cardiology|July 20, 2014
Comparison of the use of hemodynamic support in patients ≥80 years versus patients <80 years during high-risk percutaneous coronary interventions (from the Multicenter PROTECT II Randomized Study)Ashish Pershad, Ghassan Fraij, Joseph M Massaro, et al.
American Journal of Epidemiology|November 17, 2007
Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring StudyM Kyla Shea, Sarah L Booth, Joseph M Massaro, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 8, 2010
Biomarkers of the osteoprotegerin pathway: clinical correlates, subclinical disease, incident cardiovascular disease, and mortalityWolfgang Lieb, Philimon Gona, Martin G Larson, et al.
Journal of the American Heart Association|May 1, 2016
Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort StudiesParag H Joshi, Arif A Khokhar, Joseph M Massaro, et al.
The American Journal of Cardiology|February 15, 2014
Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial)George D Dangas, Annapoorna S Kini, Samin K Sharma, et al.
Circulation|June 20, 2007
Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart StudyCaroline S Fox, Joseph M Massaro, Udo Hoffmann, et al.
Pageof 43

Showing results (351-360 of 422) with videos related to

Sort By:
Pageof 43
Neurocritical Care|August 17, 2014
Thromboelastography defines late hypercoagulability after TBI: a pilot studyAllie M Massaro, Sean Doerfler, Kelsey Nawalinski, et al.
Journal of Vascular and Interventional Radiology : JVIR|August 3, 2013
Correlation of patient-reported symptom outcomes and treadmill test outcomes after treatment for aortoiliac claudicationTimothy P Murphy, Matthew R Reynolds, David J Cohen, et al.
Neurology|March 29, 2007
Inflammatory biomarkers are associated with total brain volume: the Framingham Heart StudyA L Jefferson, J M Massaro, P A Wolf, et al.
American Heart Journal|January 15, 2019
Blood kidney injury molecule-1 predicts short and longer term kidney outcomes in patients undergoing diagnostic coronary and/or peripheral angiography-Results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) studyNasrien E Ibrahim, Cian P McCarthy, Shreya Shrestha, et al.
The American Journal of Cardiology|July 20, 2014
Comparison of the use of hemodynamic support in patients ≥80 years versus patients <80 years during high-risk percutaneous coronary interventions (from the Multicenter PROTECT II Randomized Study)Ashish Pershad, Ghassan Fraij, Joseph M Massaro, et al.
American Journal of Epidemiology|November 17, 2007
Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring StudyM Kyla Shea, Sarah L Booth, Joseph M Massaro, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 8, 2010
Biomarkers of the osteoprotegerin pathway: clinical correlates, subclinical disease, incident cardiovascular disease, and mortalityWolfgang Lieb, Philimon Gona, Martin G Larson, et al.
Journal of the American Heart Association|May 1, 2016
Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort StudiesParag H Joshi, Arif A Khokhar, Joseph M Massaro, et al.
The American Journal of Cardiology|February 15, 2014
Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial)George D Dangas, Annapoorna S Kini, Samin K Sharma, et al.
Circulation|June 20, 2007
Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart StudyCaroline S Fox, Joseph M Massaro, Udo Hoffmann, et al.
Pageof 43